Oura Confidentially Files for IPO as Smart Ring Membership Nears Five Million

Oura, the company behind the health-tracking Oura Ring, has confidentially filed for an initial public offering, taking a step toward listing one of the best-known biometric wearables on the public markets. The company says it has submitted a draft registration statement on Form S-1 to the U.S. Securities and Exchange Commission for a proposed IPO of its common stock.

A confidential filing lets a company begin the SEC review process privately, before publicly disclosing its financial details and the full registration statement. Oura said the number of shares to be offered and the price range have not yet been determined, and that any offering would proceed after the SEC completes its review, subject to market conditions. The company did not commit to a timeline, though reporting on the filing points to a potential listing later in 2026.

The Oura Ring is a finger-worn device that continuously collects physiological data, syncing with a smartphone app to track metrics including sleep, heart rate, body temperature, stress, recovery, and women’s health. That places Oura among the consumer products built on continuous biometric measurement, where the value of the device depends on the sensitive health and physiological data it gathers from the wearer’s body.

Oura disclosed business figures alongside the filing news. The company said it is on track to surpass five million paid members this quarter, members who pay a subscription for the analysis layer that sits on top of the ring hardware. Oura was valued at 11 billion dollars in an October funding round that raised 900 million dollars, and Chief Executive Officer Tom Hale has said the company could approach 2 billion dollars in sales in 2026 as it invests in artificial intelligence and international expansion. The October round followed an earlier 5 billion dollar valuation reached as the company expanded.

Oura has a notable history beyond the consumer market. The U.S. Department of Defense used Oura rings during the COVID-19 pandemic to study early illness detection, and later awarded Oura a 96 million dollar contract to supply rings to military personnel, an agreement the department subsequently cancelled. The company has also moved to extend its reach into enterprise health through acquisition.

A public listing would make Oura’s financial performance, and the scale of its biometric-data business, subject to regular public disclosure for the first time.

Sources: CNBC, Bloomberg

–

By Cass Kennedy